Chen D, Li Q, Liang H, Huang L, Zhou H, Zheng X, et al
Beta-thalassemia and sickle cell disease (also called sickle cell anemia or sickle cell trait) are both inherited disorders that affect hemoglobin
households now include a GLP-1 user, up from 9 percent in January 2025, based on PwC analysis of data from Numerator, and 54 percent of surveyed users have been on the drugs for over one year, up from 38 percent in 2024
This means it acts like a hormone in your body, helping to control how hungry you feel and your blood sugar
The analysis focused on several GLP-1 medications, including injectable Ozempic for type 2 diabetes, injectable Wegovy for obesity treatment, and the oral semaglutide tablet Rybelsus
Treat confirmed hypoglycaemia immediately with 1520 g of fast-acting carbohydrate and recheck glucose after 15 minutes